Adequate pelvic lymph node dissection during radical cystectomy for muscle-invasive carcinoma urinary bladder: A systematic review and meta-analysis of randomized controlled trials comparing extended and limited lymph node dissection
Authors:
Open Access
- 1 July 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Indian Journal of Urology
- Vol. 41 (3) , 176-182
Abstract
Introduction: To compare the efficacy and safety of extended lymph node dissection (eLND) versus standard LND (sLND) in patients with bladder cancer undergoing radical cystectomy, focusing on overall survival (OS), recurrence-free survival (RFS), and complications, including symptomatic lymphoceles. Materials and Methods: A systematic review and meta-analysis were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We searched PubMed, MEDLINE, Embase, Scopus, and Cochrane databases for randomized controlled trials (RCTs) comparing eLND and sLND. The primary outcomes were OS and RFS, while secondary outcomes included complications such as lymphoceles, sepsis, and urinary tract infections. Data were extracted independently by two authors, and the risk of bias was assessed using the Cochrane RoB 2 tool. Results: Two RCTs (Gschwend et al ., 2019; Lerner et al ., 2024) were included, with a total of 1,015 patients. No significant differences were observed in OS (hazard ratio [HR]: 0.95, 95% confidence interval [CI]: 0.66–1.37) or RFS (HR: 1.00, 95% CI: 0.77–1.29) between the eLND and sLND groups. However, eLND was associated with a significantly higher incidence of symptomatic lymphoceles (risk ratio: 2.21, 95% CI 1.13–4.34) and no other major complications. The risk of publication bias was high due to the limited number of included studies. Conclusion: While eLND did not show a survival benefit over sLND, it was associated with a higher risk of lymphoceles. eLND may be beneficial in patients with higher-risk disease requiring precise staging, but sLND is a viable and less morbid alternative for most patients.Keywords
This publication has 20 references indexed in Scilit:
- Pelvic lymphadenectomy: Evaluating nodal stage migration and will rogers effect in bladder cancerUrologic Oncology: Seminars and Original Investigations, 2023
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized TrialEuropean Urology, 2019
- Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized TrialsEuropean Urology, 2014
- Clinical–Pathologic Stage Discrepancy in Bladder Cancer Patients Treated With Radical Cystectomy: Results From the National Cancer Data BaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 GuidelinesEuropean Urology, 2014
- Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center StudyEuropean Urology, 2011
- Lymphadenectomy in bladder cancer: How high is “high enough”?Urologic Oncology: Seminars and Original Investigations, 2006
- Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- IMPACT OF THE NUMBER OF LYMPH NODES RETRIEVED ON OUTCOME IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCERJournal of Urology, 2002
- The Rationale for EN Bloc Pelvic Lymph Node Dissection for Bladder Cancer Patients with Nodal Metastases: Long-Term ResultsJournal of Urology, 1993